April 18, 2025 a 08:00 am

DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated

Quest Diagnostics Incorporated - Stock Analysis

Quest Diagnostics Incorporated is a key player in the diagnostics and healthcare information services industry, showing solid performance with room for growth. The company benefits from a wide-ranging client base and a diverse product line, which supports its strong market position. However, investors should monitor the industry trends and competitive landscape closely.

Fundamental Rating

Quest Diagnostics exhibits a commendable fundamental score, suggesting a stable financial standing with areas of moderate performance in some financial ratios.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 4
Return on Assets 5
Debt to Equity 1
Price to Earnings 2
Price to Book 2

Historical Rating

The historical data indicates consistent scoring with metrics being stable over time.

Date Overall Score Discounted Cash Flow Return on Equity Return on Assets Debt to Equity Price to Earnings Price to Book
2025-04-17 3 4 4 5 1 2 2
Previous Date 3 4 4 5 1 2 2

Analyst Price Targets

Analysts provide a mixed outlook with moderate expectations for price growth.

High Low Median Consensus
$195 $165 $181 $180.25
DGX Stock Chart

Analyst Sentiment

The sentiment shows a consensus leaning towards a 'Hold' strategy.

Recommendation Count Percent Distribution
Strong Buy 0
Buy 13
Hold 14
Sell 2
Strong Sell 0

Conclusion

Quest Diagnostics Incorporated remains a steady contender in the healthcare diagnostics industry with prospects for incremental growth. While the company exhibits strong fundamentals, the ‘Hold’ consensus from analysts suggests a cautious approach in the face of market volatility and evolving industry dynamics. Investors should weigh the balanced ratio of risk to potential reward before investing. Opportunities in technological advancements may bolster future growth potential.